MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • 2023 International Congress

    Does baseline expectation of benefit predict outcome in SURE-PD3, a Randomized, Double-Blind, Placebo-Controlled, Phase III trial of Inosine in Parkinson’s disease?

    T. Mestre, E. Macklin, A. Lang, M. Schwarzschild (Ottawa, Canada)

    Objective: To evaluate the association of patient-reported baseline expectation with efficacy outcomes in a randomized placebo-controlled trial (RCT) in PD. Background: Expectation of benefit can…
  • 2023 International Congress

    Analysis of levodopa use in patients with Parkinson’s Disease during pregnancy: a systematic review of the last twenty years

    R. Albuquerque, E. Almeida, G. Herwig, G. Bolner, G. Maia, G. Mantovani, MF. Felippe, V. Müller (Porto Alegre, Brazil)

    Objective: To evaluate the role of oral levodopa in patients with Parkinson’s disease (PD) during pregnancy, using the available literature, in order to determine the…
  • 2023 International Congress

    Apathy, white-matter microstructure, and effort-based decision making in Parkinson’s Disease

    N. Vanegas-Arroyave, C. Leheron, Z. He, S. Lee, E. Huey, Y. Gazes (Houston, USA)

    Objective: To investigate the influence of reward and effort on behavior in PD patients with and without apathy, using a drift-diffusion model to analyze neuroimage…
  • 2023 International Congress

    First case of sporadic ATP6AP2 Mutation reported in Asia in a Parkinson’s Disease patient

    K. Shukla, N. Sawal (Chandigarh, India)

    Objective: Genetic analysis of Parkinson's Disease (PD) with features of spasticity by Whole Exome Sequencing (WES) and use of its result for treatment modification to…
  • 2023 International Congress

    Needs and priorities of people with Parkinson’s and care partners regarding neuropsychiatric symptoms

    J. Goldman, H. Peirce, D. Merkitch (Chicago, USA)

    Objective: To examine the experiences of people with Parkinson’s disease (PD) and care partners (CPs) regarding cognitive, mood, behavioral, and sleep issues. Background: Neuropsychiatric symptoms…
  • 2023 International Congress

    Restless legs syndrome may be associated with freezing of gait, start hesitation and falls in Parkinson’s disease

    M. Isayan, H. Hovakimyan, S. Khachatryan, Z. Tavadyan (Yerevan, Armenia)

    Objective: We aimed to assess the association between RLS and freezing of gait, start hesitation and falls. Background: Parkinson’s disease (PD) is a neurodegenerative disease…
  • 2023 International Congress

    Modulation of pallidal activity by circadian rhythms: a new variable to be accounted for closed-loop DBS?

    T. de Araujo, J. Cagle, F. Sarmento, K. Johnson, L. Almeida, C. de Hemptinne (Gainesville, USA)

    Objective: To analyze the influence of circadian rhythmson local field potentials (LFPs) recorded in the Globus Pallidus Internal (GPi) of patients with Parkinson’s disease (PD).…
  • 2023 International Congress

    Olfactory discrimination differentiate drug-induced parkinsonism and Parkinson’s disease

    IH. Kwak, JJ. Lee, MS. Kim, SY. Kang, HI. Ma, YE. Kim (Anyang-si, Republic of Korea)

    Objective: In this study, we evaluated detailed differential features of olfactory function in PD and DIP. Background: DIP is common but it is challenging to…
  • 2023 International Congress

    Dietary protein redistribution influences the efficacy of levodopa/carbidopa intestinal gel (LCIG) infusion

    Y. Ben Mordechai, S. Israeli-Korn, O. Cohen, S. Hassin-Baer (Tel Hashomer, Israel)

    Objective: To compare levodopa/carbidopa intestinal gel (LCIG) with equally distributed dietary protein (Diet_EDP) versus restricted to twice daily (Diet_RP) and Mediterranean diet (Diet_M). Background: Levodopa…
  • 2023 International Congress

    Pupil response is impaired in clinically isolated REM Sleep Behavior Disorder and Parkinsons’ Disease

    W. Hermann, M. Brandt, T. Sehr, U. Walter, H. Reichmann, A. Storch, T. Ziemssen (Rostock, Germany)

    Objective: Since easily accessible (bio-) markers are needed to predict progression and outcome in prodromal stages of neurodegenerative diseases this study was designed to evaluate…
  • « Previous Page
  • 1
  • …
  • 362
  • 363
  • 364
  • 365
  • 366
  • …
  • 553
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley